Hand Orthosis for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing the MyHand-SCI device, which helps people with C6-C7 spinal cord injuries use their hands better. The device combines physical support and smart technology to improve hand movements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
How is the MyHand-SCI Device treatment different from other treatments for spinal cord injury?
The MyHand-SCI Device is unique because it combines soft robotics and functional electrical stimulation (FES) to assist and restore hand function in people with spinal cord injury. This approach is different from traditional hand assist devices, which can be bulky and complex, as it offers a lightweight and compact solution that enhances independence in daily activities.12345
What data supports the effectiveness of the MyHand-SCI Device, MyHand-SCI Orthosis, and MyHand-SCI Robotic Hand Orthosis treatment?
Who Is on the Research Team?
Joel Stein, MD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for individuals with C6-C7 spinal cord injury who are at least 6 months post-injury and have significantly reduced hand and finger function. They must be able to consent to the study. People with open wounds, severe upper limb pain, intense spasticity, or fixed contractures that limit arm use cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Device Testing
Subjects will attend 1-20 sessions to trial a variety of the MyHand-SCI device controls and/or components. Participants will practice various grasp and release activities with the device.
Follow-up
Participants are monitored for safety and effectiveness after device testing
What Are the Treatments Tested in This Trial?
Interventions
- MyHand-SCI Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator